MERCK KGAA |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 168.68 EUR | +0.07% |
|
-0.03% | +17.11% |
| 09-09 | German Shares Cheer Likelihood of September ECB Rate Cut | MT |
| 09-03 | Merck Gets EU Approval for Keytruda Cancer Therapy | DJ |
Main competitors
| 1m. EPS revision | 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Divergence of Estimates | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| 16 | |||||||||
| 12 | |||||||||
| 17 | |||||||||
| 14 | |||||||||
| 2 | |||||||||
| - | - | ||||||||
| - | - | ||||||||
| 4 | |||||||||
| 3 | |||||||||
| 5 | |||||||||
| 4 | |||||||||
| 3 | |||||||||
| - | - | - | 2 | ||||||
| 11 | |||||||||
| - | 1 | ||||||||
| Average | 7 | ||||||||
| Weighted average by Cap. | 14 |
- Stock Market
- Equities
- MRK Stock
- Sector Merck KGaA
- Sector revisions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition